1H22 Financial Performance
Key financials
3
Revenue (RMBmm)
Operating profit 1,3,5 (RMBmm)
Operating profit margin (%)
12.0%
18.7%
20.5%
19.9%
21.8%
23.5%
24.1%
Growth (%)
17.7%
9.5%
2018-2021 CAGR: 14.3%
15.9%
13,152
11,345
10,364
CAGR: 12.0%
8,809
2018
2019
2020
2018-2021 CAGR: 20.3%
2,866
6,230
6,975
2,133
2,255
1,648
2021
1H2021
1H2022
EBITDA margin (%)
EBITDA 1,2,3,4 (RMBmm)
31.5%
2018
2019
2020
2021
CAGR: 14.8%
1,463
1,680
1H2021
1H2022
Net profit attributable to Company's shareholders 1,2,3,4 (RMBmm)
Net margin (%)
31.3%
29.3%
30.8%
31.8%
30.9%
18.7%
19.4%
19.0%
20.1%
20.9%
21.8%
2018-2021 CAGR: 13.5%
4,051
CAGR: 8.7%
3,247
3,322
2,773
2018-2021 CAGR: 15.5%
2,443
1,982
2,154
1,923
2,030
1,587
CAGR: 15.0%
1,209
1,391
2018
2019
2020
2021
1H2021
1H2022
2018
2019
2020
2021
1H2021
1H2022
WEGO威高
Notes: 1 After deduction of special items such as inventory appreciation due to the acquisition of Argon Medical in 2018 and the one-time transaction fee of the
acquisition; 2 After deduction of special item of the one-time debt replacement fee of Argon Medical in 2019; 3 Not including the impact of accounting restatement of
business under the same control in 2019 and 2020; 5 Operating profit refers to the total pre-tax profit of each segment
9
The above figures are only for the purpose of reflecting the trend at the operational level of the Company. The specific figures are subject to performance reportsView entire presentation